Compile Data Set for Download or QSAR
Report error Found 21588 Enz. Inhib. hit(s) with Target = 'Acetylcholinesterase'
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM10958((3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyr...)
Affinity DataEC50:  25nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476174((−)-N1-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476178((−)-N8-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476179((−)-N1, N8-bisnorphenylcarbamoyleseroline | ...)
Affinity DataEC50:  100nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent

TargetAcetylcholinesterase(Electric eel)
University of Missouri St. Louis

Curated by ChEMBL
LigandPNGBDBM50292572(CHEMBL15910 | 3,3-dimethylbutan-2-yl methylphospho...)
Affinity DataKd:  400nMAssay Description:Binding affinity to Electric eel AChEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Electric eel)
University of Missouri St. Louis

Curated by ChEMBL
LigandPNGBDBM50027343(CHEBI:75701 | ISOPROPYL METHYLPHOSPHONOFLUORIDATE)
Affinity DataKd:  2.20E+3nMAssay Description:Binding affinity to Electric eel AChEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50241982(CHEMBL4093201)
Affinity DataKd:  1.50E+6nMAssay Description:Binding affinity to human AChE using acetylthiocholine as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50241987(CHEMBL446997)
Affinity DataKd:  2.45E+4nMAssay Description:Binding affinity to human AChEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Electric eel)
University of Missouri St. Louis

Curated by ChEMBL
LigandPNGBDBM50240416(diethyl 4-nitrophenyl phosphate | paraoxon | O,O-d...)
Affinity DataKd:  1.70E+5nMAssay Description:Binding affinity to Electric eel AChE using acetylthiocholine as substrate measured for 30 secs by Ellman's methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Electric eel)
University of Missouri St. Louis

Curated by ChEMBL
LigandPNGBDBM50241991(CHEMBL4085438)
Affinity DataKd:  2.00E+3nMAssay Description:Binding affinity to Electric eel AChEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246558(CHEMBL4069847)
Affinity DataKd:  1.96E+6nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246559(CHEMBL4059560)
Affinity DataKd:  1.70E+4nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246564(CHEMBL4091748)
Affinity DataKd:  8.16E+5nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246565(CHEMBL4068829)
Affinity DataKd:  1.16E+5nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246559(CHEMBL4059560)
Affinity DataKd:  5.20E+4nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50333779(1,3-Bis(4-(Hydroxyimino-methyl)-pyridinium)-2-oxap...)
Affinity DataKd:  2.74E+4nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246566(CHEMBL4079076)
Affinity DataKd:  1.15E+4nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246564(CHEMBL4091748)
Affinity DataKd:  1.20E+6nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246585(CHEMBL4090842)
Affinity DataKd:  5.27E+5nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246602(CHEMBL4072579)
Affinity DataKd:  1.66E+6nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246565(CHEMBL4068829)
Affinity DataKd:  8.20E+4nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246568(CHEMBL4096126)
Affinity DataKd:  2.13E+5nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246570(CHEMBL4081509)
Affinity DataKd:  3.52E+5nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50011780(Pralidoxine chloride | PRALIDOXIME | CHEMBL748 | 2...)
Affinity DataKd:  2.76E+4nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50333779(1,3-Bis(4-(Hydroxyimino-methyl)-pyridinium)-2-oxap...)
Affinity DataKd:  3.13E+4nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246558(CHEMBL4069847)
Affinity DataKd:  1.14E+6nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246567(CHEMBL4063984)
Affinity DataKd:  2.74E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246564(CHEMBL4091748)
Affinity DataKd:  2.29E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246606(CHEMBL4099486)
Affinity DataKd:  1.47E+6nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246565(CHEMBL4068829)
Affinity DataKd:  8.90E+4nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246559(CHEMBL4059560)
Affinity DataKd:  3.54E+4nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246570(CHEMBL4081509)
Affinity DataKd:  1.22E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50011780(Pralidoxine chloride | PRALIDOXIME | CHEMBL748 | 2...)
Affinity DataKd:  3.16E+6nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246566(CHEMBL4079076)
Affinity DataKd:  4.72E+4nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246565(CHEMBL4068829)
Affinity DataKd:  4.80E+4nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246568(CHEMBL4096126)
Affinity DataKd:  1.21E+5nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50011780(Pralidoxine chloride | PRALIDOXIME | CHEMBL748 | 2...)
Affinity DataKd:  7.06E+5nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50333779(1,3-Bis(4-(Hydroxyimino-methyl)-pyridinium)-2-oxap...)
Affinity DataKd:  9.73E+4nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246559(CHEMBL4059560)
Affinity DataKd:  2.90E+4nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246566(CHEMBL4079076)
Affinity DataKd:  5.01E+4nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246602(CHEMBL4072579)
Affinity DataKd:  7.82E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246567(CHEMBL4063984)
Affinity DataKd:  1.55E+5nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246567(CHEMBL4063984)
Affinity DataKd:  1.40E+5nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50011780(Pralidoxine chloride | PRALIDOXIME | CHEMBL748 | 2...)
Affinity DataKd:  2.81E+4nMAssay Description:Reactivation of VX inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246606(CHEMBL4099486)
Affinity DataKd:  3.85E+5nMAssay Description:Reactivation of sarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246568(CHEMBL4096126)
Affinity DataKd:  1.67E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50333779(1,3-Bis(4-(Hydroxyimino-methyl)-pyridinium)-2-oxap...)
Affinity DataKd:  9.46E+5nMAssay Description:Reactivation of cyclosarin inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50246570(CHEMBL4081509)
Affinity DataKd:  8.00E+4nMAssay Description:Reactivation of tabun inhibited human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50035852(HI-6)
Affinity DataKd:  1.50E+4nMAssay Description:Reactivation of VX-induced inhibition of human AChE assessed as dissociation constant using acetylthiocholine as substrate preincubated for 30 mins f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM50260310(CHEMBL4064154)
Affinity DataKd:  2.68E+5nMAssay Description:Reactivation of sarin-induced inhibition of human AChE assessed as dissociation constant using acetylthiocholine as substrate preincubated for 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 21588 total ) | Next | Last >>
Jump to: